VEGFA and wet macular degeneration: Current FDA (Food and Drug Administration)-approved treatment for neovascular age-related macular degeneration (AMD) and complications associated with diabetic retinopathy involve frequent anti-vascular endothelial growth factor (VEGF) intravitreal injections.